Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lowell General Hospital
Participants will be randomized into treatment vs. control group. Both groups will receive regular inpatient medical treatment. Participants in the experimental arm will receive laser treatments once daily for 4 days. Treatments will be delivered to the patients in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz. Standard nursing protocols would be used to identify participant's pulmonary status throughout treatment.
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
COVID-19 positive
Pulmonary compromise requiring oxygen support of approximately 2-6 liters
Able to self prone, or support in self-sitting position
You may not be if
Ventilator management
Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
Pregnant women
Clareo Health | Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease
